Ramanatha Saralaya
Eli Lilly (Ireland)(IE)BenevolentAI (United Kingdom)(GB)
Publications by Year
Research Areas
Tuberculosis Research and Epidemiology, Neuroscience and Neuropharmacology Research, Receptor Mechanisms and Signaling, HIV/AIDS drug development and treatment, Cancer therapeutics and mechanisms
Most-Cited Works
- → A simple and rapid method to collect the cerebrospinal fluid of rats and its application for the assessment of drug penetration into the central nervous system(2008)125 cited
- → Discovery of Imidazo[1,2-a]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthesis(2017)124 cited
- → 1,4-Azaindole, a Potential Drug Candidate for Treatment of Tuberculosis(2014)109 cited
- → 4-Aminoquinolone Piperidine Amides: Noncovalent Inhibitors of DprE1 with Long Residence Time and Potent Antimycobacterial Activity(2014)94 cited
- → Lead Optimization of 1,4-Azaindoles as Antimycobacterial Agents(2014)89 cited
- → Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate(2015)73 cited
- → N-Aryl-2-aminobenzimidazoles: Novel, Efficacious, Antimalarial Lead Compounds(2014)41 cited
- → Aminoazabenzimidazoles, a Novel Class of Orally Active Antimalarial Agents(2014)30 cited
- → Scaffold morphing leading to evolution of 2,4-diaminoquinolines and aminopyrazolopyrimidines as inhibitors of the ATP synthesis pathway(2016)28 cited
- → Approach to reduce the non-specific binding in microdialysis(2012)26 cited